Literature DB >> 16636089

Health status: what does it mean for payers and patients?

Paul W Jones1.   

Abstract

Disturbances to health can be divided broadly into limitations of basic activities of daily living (washing, dressing, etc.) that are common to all patients and other limitations that depend on individual circumstances. A distinction should be drawn between health status and health-related quality of life. Health status questionnaires are standardized for "typical patients," and this should be borne in mind when interpreting such scores from studies that give an average result using population-based measurements. Such studies give a good indication to payers of the average effects of a treatment, but provide no indication other than probability of benefit to individuals. This applies even more with health improvements that manifest uniquely in each patient. Two widely used disease-specific questionnaires in chronic obstructive pulmonary disease-the Chronic Respiratory Questionnaire and the St. George's Respiratory Questionnaire-are health status, rather than quality of life, instruments. Health status scores from questionnaires provide measures of the effects of disease, not measures of the disease itself. The relationship between high health status score and increased risk of dying is due to the fact that both reflect underlying disease activity. In therapeutic studies, health status improves because the underlying disease activity has been moderated by therapy. Improved health does not improve mortality or morbidity per se. It is also important to appreciate that the impact of any measured change in health may also be determined by the patient's baseline state.

Entities:  

Mesh:

Year:  2006        PMID: 16636089     DOI: 10.1513/pats.200512-126SF

Source DB:  PubMed          Journal:  Proc Am Thorac Soc        ISSN: 1546-3222


  11 in total

Review 1.  Health-related quality of life and patient-reported outcomes in pulmonary arterial hypertension.

Authors:  Hubert Chen; Darren B Taichman; Ramona L Doyle
Journal:  Proc Am Thorac Soc       Date:  2008-07-15

2.  Utility estimation in chronic obstructive pulmonary disease: a preference for change?

Authors:  Jennifer Petrillo; Floortje van Nooten; Paul Jones; Maureen Rutten-van Mölken
Journal:  Pharmacoeconomics       Date:  2011-11       Impact factor: 4.981

3.  Factors associated with short-term recovery of health status among emergency department patients with acute exacerbations of chronic obstructive pulmonary disease.

Authors:  Chu-Lin Tsai; Brian H Rowe; Carlos A Camargo
Journal:  Qual Life Res       Date:  2009-01-04       Impact factor: 4.147

4.  Targeting lung inflammation: novel therapies for the treatment of COPD.

Authors:  Hongwei Yao; Willem I de Boer; Irfan Rahman
Journal:  Curr Respir Med Rev       Date:  2008

Review 5.  Role of clinical questionnaires in optimizing everyday care of chronic obstructive pulmonary disease.

Authors:  Paul W Jones; David Price; Thys van der Molen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2011-05-26

6.  Evaluation of a German version of the tonsil and adenoid health status instrument.

Authors:  Teresa Steinbichler; Birte Bender; Elisabeth Blassnigg; Herbert Riechelmann
Journal:  J Otolaryngol Head Neck Surg       Date:  2014-10-31

7.  Validity, reliability, and responsiveness of a new short Visual Simplified Respiratory Questionnaire (VSRQ) for health-related quality of life assessment in chronic obstructive pulmonary disease.

Authors:  T Perez; B Arnould; J-M Grosbois; V Bosch; I Guillemin; M-L Bravo; M Brun; A-B Tonnel
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-04-15

8.  Factors affecting health status in COPD patients with co-morbid anxiety or depression.

Authors:  Minna J Hynninen; Ståle Pallesen; Inger Hilde Nordhus
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007

Review 9.  Future therapeutic treatment of COPD: struggle between oxidants and cytokines.

Authors:  Willem I de Boer; Hongwei Yao; Irfan Rahman
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007

10.  Effect of tiotropium on health-related quality of life as a primary efficacy endpoint in COPD.

Authors:  A-B Tonnel; T Perez; J-M Grosbois; C Verkindre; M-L Bravo; M Brun
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.